VEGFC and neoplasm: FOXF2 can affect the EMT process, G1-S cell cycle transition33,39, Wnt/β-catenin pathway33,40–42, BMP/SMAD pathway43 and VEGF-C/VEGFR-3 pathway44 to promote or suppress the development of tumours.